Award
Delivery Order #SPE2DR26FDJ2P
Delivery Order for Letrozole Tablets under Strategic Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$1,121.25
Ceiling
$1,121.25
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2DR26FDJ2P
NAICS
424210
This delivery order contract was awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company, under a previously established indefinite delivery vehicle (IDV) strategic pharmaceutical supply contract. The procurement involves Letrozole 2.5 mg tablets, a critical pharmaceutical product. The contract ensures the timely and reliable supply of essential medication to support federal healthcare needs. The specific scope of work includes the delivery of a defined quantity of Letrozole tablets within a concise timeframe. This award falls within a longstanding multi-year framework agreement aimed at maintaining consistent access to key medications. While competitive bidding details for this delivery order are not specified, the overarching IDV was competitively established to promote reliable pharmaceutical sourcing. The performance period for this delivery order is brief, encompassing a short, focused delivery window. The contract operates within the federal supply chain context in Conshohocken, Pennsylvania, reinforcing the healthcare system's pharmaceutical distribution capabilities.
Description
4571003917!LETROZOLE 2.5 MG TABLET 90S